Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission

Original Submission
21 Jan 2025 Submitted Original manuscript
24 Jan 2025 Author responded Author comments - Mona Al-Ahmad
29 Jan 2025 Reviewed Reviewer Report
7 Feb 2025 Reviewed Reviewer Report - Victor Gonzalez-Uribe
18 Feb 2025 Author responded Author comments - Mona Al-Ahmad
Resubmission - Version 2
24 Jan 2025 Submitted Manuscript version 2
26 Feb 2025 Author responded Author comments - Mona Al-Ahmad
Resubmission - Version 3
26 Feb 2025 Submitted Manuscript version 3
Publishing
5 Mar 2025 Editorially accepted
21 Mar 2025 Article published 10.1186/s12890-025-03578-0

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us